MoneyWorks4Me

Coral Laboratories - Quaterly Results

23 May 2023 Evaluate
A decrease of about -43.03% in the sales to Rs. 114.38 millions was observed for the quarter ended March 2023. The sales stood at Rs. 200.76 millions during the similar quarter previous year.The Net Loss for the quarter ended March 2023 is Rs. -8.93 millions as compared to Net Profit of Rs. 25.47 millions of corresponding quarter ended March 2022Operating profit Margin for the quarter ended March 2023 slipped to -9.24% as compared to 25.82% of corresponding quarter ended March 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 114.38 200.76 -43.03 781.18 756.11 3.32 781.18 756.11 3.32
Other Income 11.61 15.29 -24.07 68.95 48.14 43.23 68.95 48.14 43.23
PBIDT -9.24 25.82 -135.79 107.07 130.28 -17.82 107.07 130.28 -17.82
Interest 0.18 0.52 -65.38 3.38 1.41 139.72 3.38 1.41 139.72
PBDT -9.42 34.89 -127.00 104.07 138.46 -24.84 104.07 138.46 -24.84
Depreciation 6.80 5.02 35.46 21.80 19.91 9.49 21.80 19.91 9.49
PBT -16.22 29.87 -154.30 82.27 118.55 -30.60 82.27 118.55 -30.60
TAX -7.29 4.40 -265.68 17.81 28.10 -36.62 17.81 28.10 -36.62
Deferred Tax -0.99 3.90 -125.38 -0.39 0.60 -165.00 -0.39 0.60 -165.00
PAT -8.93 25.47 -135.06 64.46 90.45 -28.73 64.46 90.45 -28.73
Equity 35.73 35.73 0.00 35.73 35.73 0.00 35.73 35.73 0.00
PBIDTM(%) -8.08 12.86 -162.81 13.71 17.23 -20.45 13.71 17.23 -20.45
Peers
Company Name CMP
Sun Pharma. Inds. 1850.10
Dr. Reddys Labs. 1201.85
Cipla 1400.20
Lupin 2095.40
Zydus Lifesciences 1187.95
View more..